Advanced in Hypertension

Dr. Robert Bourge

Cardiology
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham,, AL 
Advanced in Hypertension
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham,, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Bourge is a Cardiologist in Birmingham,, Alabama. Dr. Bourge is rated as an Advanced provider by MediFind in the treatment of Hypertension. His top areas of expertise are Heart Failure, Hypertension, Pulmonary Hypertension, Stent Placement, and Heart Transplant.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 19 articles and participated in 4 clinical trials in the study of Hypertension.

Specialties
Cardiology
Licenses
Internal Medicine in AL
Hospital Affiliations
University Of Alabama Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

University of Alabama Health Services Foundation PC
2000 6th Ave S, Birmingham,, AL 35233
Other Locations
Office
1900 University Blvd, Birmingham,, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

48 Total Publications

Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring.
Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring.
Journal: Journal of cardiac failure
Published: May 12, 2022
Similar Doctors
Suzanne Oparil
Elite in Hypertension
Dr. Suzanne Oparil
Cardiology
Elite in Hypertension
Dr. Suzanne Oparil
Cardiology
2000 6th Ave S, 
Birmingham, AL 
 (0.2 miles away)
205-801-8817
Languages Spoken:
English
See accepted insurances

Suzanne Oparil is a Cardiologist in Birmingham, Alabama. Dr. Oparil is rated as a Distinguished provider by MediFind in the treatment of Hypertension. Her top areas of expertise are Hypertension, Heart Attack, Heart Failure, Glucocorticoid-Remediable Aldosteronism, and Hormone Replacement Therapy (HRT).

Distinguished in Hypertension
Dr. Farrell Mendelsohn
Cardiology
Distinguished in Hypertension
Dr. Farrell Mendelsohn
Cardiology

Office

801 Princeton Ave SW Ste 106, 
Birmingham,, AL 
 (4.7 miles away)
205-780-4330
Languages Spoken:
English
See accepted insurances

Farrell Mendelsohn is a Cardiologist in Birmingham,, Alabama. Dr. Mendelsohn is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Stent Placement, and Thrombectomy.

Distinguished in Hypertension
Dr. David Sibley
Cardiology
Distinguished in Hypertension
Dr. David Sibley
Cardiology

Office

801 Princeton Ave SW Ste 706, 
Birmingham,, AL 
 (4.7 miles away)
205-780-4330
Languages Spoken:
English
See accepted insurances

David Sibley is a Cardiologist in Birmingham,, Alabama. Dr. Sibley is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Coronary Heart Disease, Atherosclerosis, Cardiac Ablation, and Pacemaker Implantation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bourge's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile